• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物代谢产物与移植物抗宿主病。

Microbial metabolites and graft versus host disease.

机构信息

Blood and Marrow Transplant Program, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.

出版信息

Am J Transplant. 2018 Jan;18(1):23-29. doi: 10.1111/ajt.14443. Epub 2017 Aug 29.

DOI:10.1111/ajt.14443
PMID:28742948
Abstract

The health of mammals is a reflection of the diversity and composition of the intestinal microbiota. Alterations in the composition and functions of the intestinal microbiota have been implicated in multiple disease processes. The impact of the microbiota in health and disease is in part a function of the nutrient processing and release of metabolites. Recent studies have uncovered a major role for microbial metabolites in the function of the host immune system by which they influence disease processes such as acute graft versus host disease (GVHD), which is the main complication of allogeneic hematopoietic cell transplantation (allo-HCT). The mechanisms of acute GVHD regulation by the complex microbial community and the metabolites released by them are unclear. In this review we summarize major findings of how microbial metabolites interact with the immune system and discuss how these interactions could impact acute GVHD.

摘要

哺乳动物的健康反映了肠道微生物群落的多样性和组成。肠道微生物群落的组成和功能的改变与多种疾病过程有关。微生物在健康和疾病中的影响部分是由于营养物质的处理和代谢物的释放。最近的研究发现,微生物代谢物在宿主免疫系统的功能中起着重要作用,通过它们影响疾病过程,如急性移植物抗宿主病(GVHD),这是异基因造血细胞移植(allo-HCT)的主要并发症。复杂的微生物群落和它们释放的代谢物调节急性 GVHD 的机制尚不清楚。在这篇综述中,我们总结了微生物代谢物与免疫系统相互作用的主要发现,并讨论了这些相互作用如何影响急性 GVHD。

相似文献

1
Microbial metabolites and graft versus host disease.微生物代谢产物与移植物抗宿主病。
Am J Transplant. 2018 Jan;18(1):23-29. doi: 10.1111/ajt.14443. Epub 2017 Aug 29.
2
Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.肠道微生物群影响异基因造血细胞移植后免疫耐受和肠道移植物抗宿主病。
Front Immunol. 2019 Jan 17;9:3179. doi: 10.3389/fimmu.2018.03179. eCollection 2018.
3
Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.肠菌衍生代谢物与异基因造血细胞移植组织间的串扰。
Front Immunol. 2021 Aug 27;12:703298. doi: 10.3389/fimmu.2021.703298. eCollection 2021.
4
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.异基因造血细胞移植、微生物组与移植物抗宿主病。
Gut Microbes. 2023 Jan-Dec;15(1):2178805. doi: 10.1080/19490976.2023.2178805.
5
The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.肠道微生物群在基于抗胸腺细胞球蛋白的清髓性异基因造血细胞移植中的影响
Cancer. 2022 Apr 1;128(7):1402-1410. doi: 10.1002/cncr.34091. Epub 2022 Jan 25.
6
[Induction and regulation of intestinal graft-versus-host disease by the intestinal microbiota].[肠道微生物群对肠道移植物抗宿主病的诱导与调节]
Rinsho Ketsueki. 2024;65(9):1140-1147. doi: 10.11406/rinketsu.65.1140.
7
Effect of GVHD on the gut and intestinal microflora.移植物抗宿主病对肠道和肠道微生物群的影响。
Transpl Immunol. 2024 Feb;82:101977. doi: 10.1016/j.trim.2023.101977. Epub 2024 Jan 5.
8
Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.肠道微生物群、微生物衍生代谢物与移植物抗宿主病。
Cancer Med. 2024 Feb;13(3):e6799. doi: 10.1002/cam4.6799. Epub 2024 Jan 18.
9
Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.微生物组:移植物抗宿主病的新兴新前沿。
Dig Dis Sci. 2019 Mar;64(3):669-677. doi: 10.1007/s10620-018-5369-9. Epub 2018 Dec 7.
10
A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD.一个有前景的见解:肠道微生物群在 GI-GVHD 中的潜在影响和治疗价值。
Oxid Med Cell Longev. 2022 May 5;2022:2124627. doi: 10.1155/2022/2124627. eCollection 2022.

引用本文的文献

1
Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions.通过靶向异基因造血干细胞移植中的肠道微生物群动态来推进移植物抗宿主病的治疗策略:当前证据和未来方向
Mol Med. 2025 Jan 3;31(1):2. doi: 10.1186/s10020-024-01060-x.
2
Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.肠道微生物群、微生物衍生代谢物与移植物抗宿主病。
Cancer Med. 2024 Feb;13(3):e6799. doi: 10.1002/cam4.6799. Epub 2024 Jan 18.
3
Application of Mendelian randomization to assess host gene-gut microbiota correlations in patients with esophageal cancer.
应用孟德尔随机化评估食管癌患者宿主基因与肠道微生物群的相关性。
Front Microbiol. 2023 Dec 21;14:1309596. doi: 10.3389/fmicb.2023.1309596. eCollection 2023.
4
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.粪便微生物组的保存与移植物抗宿主病严重程度降低有关。
Blood. 2022 Dec 1;140(22):2385-2397. doi: 10.1182/blood.2021015352.
5
Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients.异基因干细胞移植受者移植前的系统脂质组学概况
Cancers (Basel). 2022 Jun 13;14(12):2910. doi: 10.3390/cancers14122910.
6
Gut microbiome profiles and associated metabolic pathways in patients of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.患有抗干扰素-γ自身抗体的成人发病免疫缺陷患者的肠道微生物群特征及相关代谢途径
Sci Rep. 2022 Jun 1;12(1):9126. doi: 10.1038/s41598-022-13289-9.
7
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation.肠道微生物群评分可预测异基因造血干细胞移植后的生存率。
Ann Hematol. 2022 Jun;101(6):1283-1294. doi: 10.1007/s00277-022-04817-8. Epub 2022 Mar 25.
8
Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.近期代谢进展在预防和治疗急、慢性移植物抗宿主病中的作用
Front Immunol. 2021 Oct 12;12:757836. doi: 10.3389/fimmu.2021.757836. eCollection 2021.
9
Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.GVHD 导致组织损伤机制的新见解。
Front Immunol. 2021 Aug 27;12:713631. doi: 10.3389/fimmu.2021.713631. eCollection 2021.
10
Indole derivatives, microbiome and graft versus host disease.吲哚衍生物、微生物组与移植物抗宿主病。
Curr Opin Immunol. 2021 Jun;70:40-47. doi: 10.1016/j.coi.2021.02.006. Epub 2021 Feb 26.